1Thumboo J, Uramoto K, O'Fallon WM. A comparative study of the clinical manifestations of systemic lupus erythematosus in caucasions in rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992 [ J ]. Arthritis Rheum,2001,45 (6) :494 - 500.
2Wong SN, Tse KC, Lee TL, et al. Lupus nephritis in Chinese children a territory - wide cohort study in Hong Kong [ J ]. Pediatr Nephrol,2006,21 (8) :1104 - 1112.
3Carreno L, Lopez - Longo FJ, Monteagudo I, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus [ J ]. Lupus, 1999,8 (4) :287 - 292.
6Weening JJ,D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited [ J ]. Kidney Int ,2004,65 ( 2 ) :521 - 530.
7Valeri A, Radhakrishnan J, Estes D, et al. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: A prospective five - year study[J]. Clin Nephrol,1994 ,42(2) :71 -78.
8Houssiau FA, Vasconcelos C, D'Cruz D, et al. Immunosuppressive therapy in lupus nephritis : The Euro - Lupus Nephritis Trial, a randomized trial of low- dose versus high -dose intravenous cyclophosphamide[ J]. Arthritis Rheum,2002,46(8) :2121 -2131.
9Contreras G, Pardo V, Leclercq B, et al. Sequential therapies for proliferative lupus nephritis[ J]. N Engl J Med,2004 ,350(10) :971 -980.
10Grootscholten C, Bajema IM, Florquin S, et al. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis [ J ]. Arthritis Rheum, 2007,56 (3) :924 -937.
